Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-03-29
1997-08-19
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 59, 536114, 536118, 536122, 5361231, A61K 31715
Patent
active
056588933
ABSTRACT:
A method is provided for inhibiting rotavirus infection of human cells by treating the rotavirus with a carrageenan. The most effective agent in inhibiting cellular rotavirus infection is lambda-carrageenan, which may be formulated in a liquid and ingested enterally. A composition containing lambda-carrageenan is an aspect of the invention.
REFERENCES:
patent: 5288704 (1994-02-01), Ungheri et al.
Superti, et al., "Effect of polyions on the infectivity of SA-11 rotavirus in LCC-MK2 cells," Comp. Immun. Microbiol. Infect. Dis., vol. 16; No. 1, 1993, pp. 55-62.
Murray et al., "Medical Microbiology", Mosby, 1994, pp. 62 and 63.
Yolken et al., "Human Milk Mucen Inhibits Rotavirus Replication and Prevents Experimental Gastroenteritis", Journal of Clinical Investigation 90, 1984-1991, (1992).
Hoshino et al., "Rotavirus Vaccine Development for the Prevention of Severe Diarrhia in Infants and Young Children", Trends in Microbiology 2:242-249, (1994).
DeClerq, "Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target with Which They Interact", Advances in Virus Research 42:2, (1993).
DeClerq, "Selective Virus Inhibitors", Microbiologice 13:165-178, (1990).
Gonzalez et al., "Polysaccharides as Antiviral Agents: Antiviral Activity of Carrageenan", Antimicrobial Agents and Chemotherapy 31(9):1388-1393 (1987).
Mizumoto et al., "Sulfated Homopolysaccharides with Immuno-Modulating Activities are More Potent Anti-HTLV-III Agents Than Sulfated Heteropolysaccharides", Japanese Journal of Experimental Medicine 58(3):145-151, (1988).
Nakashima et al., "Purification and Characterization of an Avian Myeloblastosis and Human Immunodeficiency Virus Reverse Trranscriptase Inhibitor, Sulfated Polysaccharides Extracted from Sea Algae", Antimicrobial Agents and Chemotherapy 31(10):1524-1528, (1987).
Girond et al., "Antiviral Activity of Carrageenan on Hepatities A Virus Replication in Cell Culture", Research in Virology 142:261-270, (1991).
Gerna et al., "Immunoperoxidase Techniques for Rapid Human Cytomegalovirus Identification", Archives on Virology 50:311-321 (1984).
Kitamoto et al., "Comparative Growth of Different Rotavirus Strains in Differentiated Cells (MA 104, HerG2, and CaCo-2)" Virology 184:729-737 (1991).
Anderson Steven Neal
Kirchner Stephen John
Mazer Terrence Bruce
Schaller Joseph Paul
Abbott Laboratories
Brainard T. D.
Drayer L. R.
Nickey D. O.
Wilson James O.
LandOfFree
Method for inhibition of rotavirus infection with carrageenan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibition of rotavirus infection with carrageenan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibition of rotavirus infection with carrageenan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1104865